• Info
  • Insider Ownership

Insider Trading & Ownership of Jeff E. Knight

Location
San Diego, CA
Summary
The estimated net worth of Jeff E. Knight is at least $4,222,088 dollars as of 10 Apr 2026. Jeff E. Knight is the Chief Dev. & Operating Officer of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $4.22M.
Signature
/s/ Tobin Schilke, as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jeff E. Knight and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sponsored

Quick Takeaways

  • Jeff E. Knight has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $4,222,088.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Crinetics Pharmaceuticals, Inc. ($4,222,088).
  • Past-year value change for that position: -$3,785,448.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jeff E. Knight

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRNX Crinetics Pharmaceuticals, Inc. Chief Dev. & Operating Officer $4,222,088 -$3,785,448 -47% 08 Apr 2026

Insider Transactions Reported by Jeff E. Knight:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.